SEG (SEG) Stock Price & Analysis
SEG (SEG) rose 0.00% to USD 26.04 as of July 25, 2026 at 01:47 UTC, according to Nexqual real-time market data.
SEG last closed at USD 26.04; the session ranged USD 25.95–26.46 on volume of 26,613 shares. Market capitalization is —, with a 52-week range of USD 17.74–28.34 (NYQ). Source: Nexqual, July 25, 2026 at 01:47 UTC.
Key Statistics (as of July 25, 2026 at 01:47 UTC)
| Price | USD 26.04 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 26.04 |
| Open | USD 26.04 |
| Day Range | USD 25.95 – 26.46 |
| 52-Week Range | USD 17.74 – 28.34 |
| Volume | 26,613 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (SEG)
Nexqual's technical model rates SEG "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 01:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.78 (neutral) |
| vs SMA50 | Above (USD 25.12) |
| MACD | 0.26 (positive) |
From SEG's Latest SEC 10-K Filing (filed 2026-03-04)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| QNTM | Quantum Biopharma Ltd. | USD 2.99 | ▲ 4.91% |
| KMAG | KMA GLOBAL SOLUTIONS INTL INC | USD 0 | ▲ 0% |
| SGI | Somnigroup International Inc. | USD 71.56 | ▲ 2.02% |
| STK | Columbia Seligman Premium Techn | USD 47.37 | ▼ 5.32% |
| ASND | Ascendis Pharma A/S | USD 253.86 | ▲ 0.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:47 UTC. This page is informational and not investment advice.